Patent · US Active

Family of PFKFB3 inhibitors with anti-neoplastic activities

US8557823B2 · kind B2 · utility

18Cited by
0References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 30, 2011
Grant dateOct 15, 2013
Priority date
Expiry dateNov 30, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A methods and compounds for inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) are described. Also described are methods of inhibiting cell proliferation, treating cancer, and screening compounds to determine their ability to inhibit PFKFB3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.